
Total number of projects: 2
As coordinator: 0
As participant: 1
Sole participant: 1
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2021 | 0 | 6.900.000 | 186.188 | 1 | ||
| 2017 | 50.000 | 0 | 50.000 | 1 | ||
Total number of partners: 7
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 7
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2021-02-01 | Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine | TIGER | participant | 6.900.000 | 8 |
| 2017-12-01 | EXtended Analysis of Circulating Tumour DNA to improve cancer management strategies | EXACT-dna | coordinator | 50.000 | 1 |